Sedana Medical AB (publ)
STO:SEDANA
Sedana Medical AB (publ)
Cash from Operating Activities
Sedana Medical AB (publ)
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sedana Medical AB (publ)
STO:SEDANA
|
Cash from Operating Activities
-kr11.8m
|
CAGR 3-Years
34%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Elekta AB (publ)
STO:EKTA B
|
Cash from Operating Activities
kr2.5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
S
|
Surgical Science Sweden AB
STO:SUS
|
Cash from Operating Activities
kr137.2m
|
CAGR 3-Years
52%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
CellaVision AB
STO:CEVI
|
Cash from Operating Activities
kr198.4m
|
CAGR 3-Years
8%
|
CAGR 5-Years
10%
|
CAGR 10-Years
17%
|
|
|
Getinge AB
STO:GETI B
|
Cash from Operating Activities
kr4.6B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
Arjo AB (publ)
STO:ARJO B
|
Cash from Operating Activities
kr1.5B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
Sedana Medical AB (publ)
Glance View
Sedana Medical AB is a medical technology company, which engages in the development, manufacture, and sale of medical devices and drug development for future projects around AnaConDa. The company is headquartered in Danderyd, Stockholm. The company went IPO on 2017-06-21. The company develops, markets and sales medical devices and conducts drug development for future projects around AnaConDa technology. The AnaConDa technology delivery enables of volatile anaesthetics to invasively ventilated patients. The products portfolio comprises disposable medical devices AnaConDa for administration of volatile anaesthetics, AnaConDa syringes, FlurAbsorb charcoal filters for removing halogenated hydrocarbon anaesthetic gases, different lines and connectors which can be used to connect the FlurAbsorb filter, adaptors, among others. The Company’s main shareholders are board members, Linc AB and Magiola Consulting AB.
See Also
What is Sedana Medical AB (publ)'s Cash from Operating Activities?
Cash from Operating Activities
-11.8m
SEK
Based on the financial report for Dec 31, 2024, Sedana Medical AB (publ)'s Cash from Operating Activities amounts to -11.8m SEK.
What is Sedana Medical AB (publ)'s Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-6%
Over the last year, the Cash from Operating Activities growth was 69%. The average annual Cash from Operating Activities growth rates for Sedana Medical AB (publ) have been 34% over the past three years , -6% over the past five years .
You don't have any saved screeners yet